Answers are grounded in this paper and cite their sources.
The recommendation for the Pfizer-BioNTech COVID-19 vaccine should be implemented in conjunction with ACIP's interim recommendation for allocating initial supplies of COVID-19 vaccines (2). The ACIP recommendation for the use of the Pfizer-BioNTech COVID-19 vaccine under EUA is interim and will be updated as additional information becomes available.
No takes yet. Share an insight, caveat, or question.
Oliver et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: